Skip to content

Research at St Andrews

Do participants in adjuvant breast cancer trials reflect the breast cancer patient population?

Research output: Contribution to journalArticle


Shaun Treweek, Ruth Dryden, Colin McCowan, Alison Harrow, Alastair Thompson

School/Research organisations


To describe the proportion of women in Tayside, Scotland diagnosed with early breast cancer who would have been eligible for influential adjuvant breast cancer trials.

Phase III trials of adjuvant treatment for breast cancer referenced in five national guidelines were shortlisted by breast cancer specialists to identify the twelve considered most influential. Eligibility criteria were extracted from protocols and applied to a 16-year cohort of women who had received a diagnosis of breast cancer and the proportion meeting trial criteria calculated. The criteria used clinically in Tayside to make decisions about use of the trial treatments were also applied to the cohort. Finally, the proportion of women receiving adjuvant endocrine therapy as part of their care and who would have been eligible for the trial evaluating that therapy was calculated.

Of the cohort's 4811 women, 3535 (73%) were eligible for at least one trial but eligibility for an individual trial rarely exceeded 45%. There were substantial differences between the proportion of women meeting trial eligibility criteria and the proportion considered clinically eligible for the same treatment. The proportion of women receiving an endocrine therapy as part of their care who would also have been eligible for the trial evaluating that treatment ranged from 17% to 56%.

Clinical eligibility criteria may be at variance with trial criteria. For adjuvant endocrine therapy, a substantial proportion of women who would have been ineligible for a trial nevertheless received the trial treatment as part of their care.


Original languageEnglish
Pages (from-to)907-914
JournalEuropean Journal of Cancer
Issue number8
Early online date7 Apr 2015
Publication statusPublished - May 2015

    Research areas

  • Breast cancer, Adjuvant treatment, Phase III trials, Applicability, Generalisability, Record linkage

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors

    Mark, P. B., Papworth, R., Ramparsad, N., Tomlinson, L. A., Sahwney, S., Black, C., McConnachie, A. & McCowan, C., 3 Jan 2020, In : British Journal of Clinical Pharmacology. Early View, 11 p.

    Research output: Contribution to journalArticle

  2. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study

    Kotzur, M., McCowan, C., Macdonald, S., Wyke, S., Gatting, L., Campbell, C., Weller, D., Crighton, E., Steele, R. & Robb, K., 26 Dec 2019, In : BMJ Quality & Safety. Online First

    Research output: Contribution to journalArticle

  3. Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study

    McCowan, C., McSkimming, P., Papworth, R., Kotzur, M., McConnachie, A., Macdonald, S., Wyke, S., Crighton, E., Campbell, C., Weller, D., Steele, R. JC. & Robb, K. A., 15 Oct 2019, In : British Journal of Cancer. 121, 8, p. 710–714 5 p.

    Research output: Contribution to journalArticle

  4. Healthcare disparities for women hospitalised with myocardial infarction and angina

    Jackson, A. M., Zhang, R., Robertson, K., Lindsay, M., Morris, T., Forbes, B., Papworth, R., McConnachie, A., Mangion, K., Jhund, P. S., McCowan, C. & Berry, C., 25 Jul 2019, In : European Heart Journal - Quality of Care and Clinical Outcomes.

    Research output: Contribution to journalArticle

  5. Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study

    Gray, C. M., Wyke, S., Zhang, R., Anderson, A. S., Barry, S., Brennan, G., Briggs, A., Boyer, N., Bunn, C., Donnachie, C., Grieve, E., Kohli-Lynch, C., Lloyd, S., McConnachie, A., McCowan, C., McLean, A., Mutrie, N. & Hunt, K., 1 Jul 2018, In : Public Health Research. 6, 9

    Research output: Contribution to journalArticle

Related by journal

  1. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis

    van der Kooi, A. L., Kelsey, T. W., van den Heuvel-Eibrink, M., Laven, J. S. E., Wallace, W. H. B. & Anderson, R. A., Apr 2019, In : European Journal of Cancer. 111, p. 126-137

    Research output: Contribution to journalArticle

  2. Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway

    Riches, A., Campbell, E., Borger, E. & Powis, S., Mar 2014, In : European Journal of Cancer. 50, 5, p. 1025-34 10 p.

    Research output: Contribution to journalArticle

  3. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

    Anderson, R., Rosendahl, M., Kelsey, T. & Cameron, D., Nov 2013, In : European Journal of Cancer. 49, 16, p. 3404-3411

    Research output: Contribution to journalArticle

ID: 257571862